Metin Kement
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Metin Kement has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Oncel
Department of General Surgery, Kartal Education and Research Hospital, Istanbul, Turkey
5 shared publications Nejdet Bildik
Univ Hlth Sci, Kartal Training & Res Hosp, Dept Gen Surg, Istanbul, Turkey
5 shared publications- Mehmet Eser
Department of General Surgery, School of Medicine, Istinye University, Istanbul 34010, Turkey
4 shared publications - Selçuk Kaya
Department of General Surgery, University of Health Sciences, Kartal Dr. Lütfi Kırdar Training and Research Hospital, İstanbul-Turkey
4 shared publications - Atıf Tekin
Department of General Surgery, Bağcılar Medipol Mega University Hospital, İstanbul, Türkiye
3 shared publications Cem Gezen
3 shared publications
Latest Publications
- 1 October 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (10) , 1042-1045
The role of C-reactive protein (CRP) and procalcitonin in predicting anastomotic leakage after lower gastrointestinal system operations
Aim Anastomotic leakage is a significant problem in lower gastrointestinal surgery that can lead to serious complications. This study aimed to investigate the effects of CRP and procalcitonin on anastomotic leakage in patients undergoing lower gastrointestinal surgery. Methods The study included 303 patients who underwent lower gastrointestinal surgery at the Department of General Surgery at Istanbul Medipol University Mega Hospital Complex between March 2013 and May 2016. Patients were divided into two categories: leakage (n = 29) and non-leakage (n = 274). Patient demographics and clinical data, along with CRP, leukocyte count, and procalcitonin levels on postoperative days 3 and 5, were analyzed. Results The ileocolic anastomosis region was significantly more common in the leaking group (P < .05). Complication rates differed significantly, with a higher rate of wound infection in the leaking group (P < .05). Sensitivity of CRP on the 3rd day was 79.3%, and on the 5th day, 72.4%. For procalcitonin, sensitivity on the 3rd day was 79.3% and on the 5th day after the operation was 75.9%. ROC analysis results showed that the area under the curve was the highest for CRP on the 5th day, followed by procalcitonin on the 3rd day, CRP on the 3rd day, and procalcitonin on the 5th day. All predictive values for both indicators on both measuring days were over 70%. Conclusion CRP and procalcitonin levels on postoperative days 3 and 5 may be diagnostic of anastomotic leaks in lower gastrointestinal surgery. Further studies on this topic are recommended for greater predictive value.
- 1 October 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (10) , 1042-1045
The role of C-reactive protein (CRP) and procalcitonin in predicting anastomotic leakage after lower gastrointestinal system operations
Aim Anastomotic leakage is a significant problem in lower gastrointestinal surgery that can lead to serious complications. This study aimed to investigate the effects of CRP and procalcitonin on anastomotic leakage in patients undergoing lower gastrointestinal surgery. Methods The study included 303 patients who underwent lower gastrointestinal surgery at the Department of General Surgery at Istanbul Medipol University Mega Hospital Complex between March 2013 and May 2016. Patients were divided into two categories: leakage (n = 29) and non-leakage (n = 274). Patient demographics and clinical data, along with CRP, leukocyte count, and procalcitonin levels on postoperative days 3 and 5, were analyzed. Results The ileocolic anastomosis region was significantly more common in the leaking group (P < .05). Complication rates differed significantly, with a higher rate of wound infection in the leaking group (P < .05). Sensitivity of CRP on the 3rd day was 79.3%, and on the 5th day, 72.4%. For procalcitonin, sensitivity on the 3rd day was 79.3% and on the 5th day after the operation was 75.9%. ROC analysis results showed that the area under the curve was the highest for CRP on the 5th day, followed by procalcitonin on the 3rd day, CRP on the 3rd day, and procalcitonin on the 5th day. All predictive values for both indicators on both measuring days were over 70%. Conclusion CRP and procalcitonin levels on postoperative days 3 and 5 may be diagnostic of anastomotic leaks in lower gastrointestinal surgery. Further studies on this topic are recommended for greater predictive value.
- Open Access
- 30 June 2026
- Published by Springer Nature in Updates in Surgery
- p. 1-9
Risk factors for inferior right hepatic vein occlusion following right lobe living donor liver transplantation: a single-center experience with 240 cases
This study aims to analyze the early and long-term outcomes of inferior right hepatic vein (IRHV) reconstruction and identify risk factors associated with IRHV occlusion in right lobe living donor liver transplantations (RL-LDLT). This retrospective cohort study included patients who underwent RL-LDLT with IRHV reconstruction at Institution between January 1, 2021, and December 31, 2023. Data were collected from hospital records, surgical notes, anesthesia records, radiology reports, and patient files. Patients were divided into three groups based on IRHV patency status: patent and early occluded, and late occluded. Preoperative, intraoperative, and postoperative data were analyzed. A total of 204 patients were included in the study. The mean follow-up period was 750.34 ± 364.3 days. IRHV remained patent in 69.61% (n = 142) of patients, whereas 30.39% (n = 62) experienced IRHV occlusion. Early IRHV occlusion (within 30 days) occurred in 52 patients (83.9% of occluded cases). In early occluded cases, the mean IRHV diameter was significantly smaller (4.92 ± 1.61 mm) compared to the open group (6.02 ± 1.72 mm; p < 0.001). ROC analysis identified an IRHV diameter ≤ 5 mm as a cutoff value for predicting occlusion risk (AUC = 0.704; p < 0.001). In long-term follow-up, another 10 patients’ IRHV occluded, late occluded patients were significantly younger (40.63 ± 14.56 vs. 53.21 ± 13.54 years; p = 0.005), had lower body weight (64.30 ± 13.02 vs. 76.55 ± 12.78 kg; p = 0.004), and lower BMI (22.72 ± 3.78 vs. 27.43 ± 4.07 kg/m 2 ; p = 0.001). Additionally, the GWRW ratio was significantly higher in the late occluded group ( p < 0.001), with a mean GWRW ratio of 1.08 ± 0.21 in the open group and 1.43 ± 0.35 in the occluded group. IRHV occlusion was primarily associated with smaller vein diameter (≤ 5 mm) and single anastomosis. This study highlights the need for optimized surgical techniques and perioperative management strategies to enhance IRHV patency, improve graft function, and reduce venous complications in RL-LDLT.
- 30 June 2026
- Published by Springer Nature in Updates in Surgery
- p. 1-9
Open AccessRisk factors for inferior right hepatic vein occlusion following right lobe living donor liver transplantation: a single-center experience with 240 cases
This study aims to analyze the early and long-term outcomes of inferior right hepatic vein (IRHV) reconstruction and identify risk factors associated with IRHV occlusion in right lobe living donor liver transplantations (RL-LDLT). This retrospective cohort study included patients who underwent RL-LDLT with IRHV reconstruction at Institution between January 1, 2021, and December 31, 2023. Data were collected from hospital records, surgical notes, anesthesia records, radiology reports, and patient files. Patients were divided into three groups based on IRHV patency status: patent and early occluded, and late occluded. Preoperative, intraoperative, and postoperative data were analyzed. A total of 204 patients were included in the study. The mean follow-up period was 750.34 ± 364.3 days. IRHV remained patent in 69.61% (n = 142) of patients, whereas 30.39% (n = 62) experienced IRHV occlusion. Early IRHV occlusion (within 30 days) occurred in 52 patients (83.9% of occluded cases). In early occluded cases, the mean IRHV diameter was significantly smaller (4.92 ± 1.61 mm) compared to the open group (6.02 ± 1.72 mm; p < 0.001). ROC analysis identified an IRHV diameter ≤ 5 mm as a cutoff value for predicting occlusion risk (AUC = 0.704; p < 0.001). In long-term follow-up, another 10 patients’ IRHV occluded, late occluded patients were significantly younger (40.63 ± 14.56 vs. 53.21 ± 13.54 years; p = 0.005), had lower body weight (64.30 ± 13.02 vs. 76.55 ± 12.78 kg; p = 0.004), and lower BMI (22.72 ± 3.78 vs. 27.43 ± 4.07 kg/m 2 ; p = 0.001). Additionally, the GWRW ratio was significantly higher in the late occluded group ( p < 0.001), with a mean GWRW ratio of 1.08 ± 0.21 in the open group and 1.43 ± 0.35 in the occluded group. IRHV occlusion was primarily associated with smaller vein diameter (≤ 5 mm) and single anastomosis. This study highlights the need for optimized surgical techniques and perioperative management strategies to enhance IRHV patency, improve graft function, and reduce venous complications in RL-LDLT.
- Open Access
- 15 April 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Determinants influencing decision-making for operative and perioperative management of grade III and IV hemorrhoidal disease: secondary analysis of a multicenter nationwide prospective cohort study
Purpose: With multiple treatment options available for hemorrhoidal disease (HD), identifying factors that influence surgical and perioperative management decisions is essential, particularly in advanced cases. This study aimed to determine the patient and disease-related determinants affecting the choice of surgical technique and perioperative management in patients with Grade III and IV HD, thereby addressing inter-institutional variations in treatment approaches. Methods: A secondary analysis was performed on data from a nationwide, multicenter prospective cohort study. The study included 315 patients diagnosed with Grade III (72%) and Grade IV (28%) HD, with a mean age of 43.7 ± 11.4 years and a male predominance (76.7%). Preoperative data, including patient demographics, comorbidities (ASA scores), symptom severity, and clinical findings, were collected at participating governmental and private hospitals. Surgical techniques were classified as excisional or non-excisional, while anesthesia type, use of perianal or pudendal analgesia, and hospitalization duration were determined by the surgical teams. Hospital type was also recorded. Multivariable analyses were conducted to identify factors influencing the choice of surgical techniques, anesthesia, analgesia application, and the decision for outpatient procedures. Results: Multivariate analysis revealed that the presence of thrombosis significantly influenced the choice of surgical technique (OR: 7.2, CI: 2.8–12.7, p = 0.001), while hospital category also played an important role (OR: 5.1, CI: 2.7–9.7, p = 0.001). For anesthesia type, factors such as disease grade (OR: 3.3, CI: 1.6–6.7, p = 0.001), hospital category (OR: 9, CI: 4.1–19.9, p < 0.001), and surgical technique (OR: 6.8, CI: 3–15.3, p < 0.001) were significant determinants. The decision to use perianal or pudendal analgesia was influenced by hospital category (OR: 27.1, CI: 11.7–62.6, p < 0.001) and the presence of incontinence (OR: 0.2, CI: 0.04–0.93, p = 0.04). Outpatient management was associated with disease grade (OR: 2.3, CI: 1.1–4.8, p = 0.023), hospital category (OR: 2, CI: 1.2–3.2, p = 0.011), higher comorbidity (ASA ≥ 3, OR: 3.3, CI: 1.8–3.2, p = 0.007), and the selected surgical technique (OR: 3.1, CI: 1.6–5.8, p = 0.001). Conclusion: Significant inter-institutional variations exist in the management of advanced HD. Among various factors, the presence of thrombosis emerges as the predominant determinant in surgical decision-making, providing valuable insights for standardizing treatment protocols and reducing practice variability.
- 15 April 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Open AccessDeterminants influencing decision-making for operative and perioperative management of grade III and IV hemorrhoidal disease: secondary analysis of a multicenter nationwide prospective cohort study
Purpose: With multiple treatment options available for hemorrhoidal disease (HD), identifying factors that influence surgical and perioperative management decisions is essential, particularly in advanced cases. This study aimed to determine the patient and disease-related determinants affecting the choice of surgical technique and perioperative management in patients with Grade III and IV HD, thereby addressing inter-institutional variations in treatment approaches. Methods: A secondary analysis was performed on data from a nationwide, multicenter prospective cohort study. The study included 315 patients diagnosed with Grade III (72%) and Grade IV (28%) HD, with a mean age of 43.7 ± 11.4 years and a male predominance (76.7%). Preoperative data, including patient demographics, comorbidities (ASA scores), symptom severity, and clinical findings, were collected at participating governmental and private hospitals. Surgical techniques were classified as excisional or non-excisional, while anesthesia type, use of perianal or pudendal analgesia, and hospitalization duration were determined by the surgical teams. Hospital type was also recorded. Multivariable analyses were conducted to identify factors influencing the choice of surgical techniques, anesthesia, analgesia application, and the decision for outpatient procedures. Results: Multivariate analysis revealed that the presence of thrombosis significantly influenced the choice of surgical technique (OR: 7.2, CI: 2.8–12.7, p = 0.001), while hospital category also played an important role (OR: 5.1, CI: 2.7–9.7, p = 0.001). For anesthesia type, factors such as disease grade (OR: 3.3, CI: 1.6–6.7, p = 0.001), hospital category (OR: 9, CI: 4.1–19.9, p < 0.001), and surgical technique (OR: 6.8, CI: 3–15.3, p < 0.001) were significant determinants. The decision to use perianal or pudendal analgesia was influenced by hospital category (OR: 27.1, CI: 11.7–62.6, p < 0.001) and the presence of incontinence (OR: 0.2, CI: 0.04–0.93, p = 0.04). Outpatient management was associated with disease grade (OR: 2.3, CI: 1.1–4.8, p = 0.023), hospital category (OR: 2, CI: 1.2–3.2, p = 0.011), higher comorbidity (ASA ≥ 3, OR: 3.3, CI: 1.8–3.2, p = 0.007), and the selected surgical technique (OR: 3.1, CI: 1.6–5.8, p = 0.001). Conclusion: Significant inter-institutional variations exist in the management of advanced HD. Among various factors, the presence of thrombosis emerges as the predominant determinant in surgical decision-making, providing valuable insights for standardizing treatment protocols and reducing practice variability.
- Open Access
- 8 January 2026
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 41 (1) , 21
Risk factors for non-reversal of diverting ileostomies: a retrospective analysis of 456 patients
Purpose Diverting ileostomies are routinely created during low rectal cancer surgery, yet 15–30% remain permanent. Understanding predictors of non-reversal is essential for informed patient counseling. This study investigated factors preventing ileostomy closure following colorectal surgery, primarily for rectal malignancy. Methods This retrospective cohort study analyzed prospectively collected data from patients undergoing diverting ileostomy creation (January 2015–December 2020). Exclusions included early postoperative mortality (within 30 days), follow-up less than 6 months, or missing primary outcome data. Demographics, surgical details, and reversal outcomes were analyzed. Multivariable logistic regression identified independent predictors of non-reversal. Results Of 508 patients, 456 met inclusion criteria (mean age 58.9 ± 13.2 years, 63.8% male). Malignancy accounted for 96.7% of cases, with low anterior resection performed in 83.8%. Ileostomy closure was achieved in 364 patients (79.8%) at a median of 6 months (mean 7.4 ± 5.3). The non-reversal rate was 20.2% (92 patients). Main reasons included mortality (35.8%), metastatic disease (23.9%), and anastomotic complications (22.8%). Multivariable analysis identified ASA score 3–4 (OR 2.68, 95% CI 1.58–4.54, p < 0.001) and malignant pathology (OR 5.12, 95% CI 1.23–21.3, p = 0.025) as independent predictors of non-reversal. Age showed statistical but limited clinical significance. Conclusion One in five patients with diverting ileostomies will not undergo reversal. High ASA scores, malignant disease, mortality, metastatic progression, and anastomotic complications are primary barriers. These findings emphasize the need for realistic preoperative counseling regarding permanent stoma risk.
- 8 January 2026
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 41 (1) , 21
Open AccessRisk factors for non-reversal of diverting ileostomies: a retrospective analysis of 456 patients
Purpose Diverting ileostomies are routinely created during low rectal cancer surgery, yet 15–30% remain permanent. Understanding predictors of non-reversal is essential for informed patient counseling. This study investigated factors preventing ileostomy closure following colorectal surgery, primarily for rectal malignancy. Methods This retrospective cohort study analyzed prospectively collected data from patients undergoing diverting ileostomy creation (January 2015–December 2020). Exclusions included early postoperative mortality (within 30 days), follow-up less than 6 months, or missing primary outcome data. Demographics, surgical details, and reversal outcomes were analyzed. Multivariable logistic regression identified independent predictors of non-reversal. Results Of 508 patients, 456 met inclusion criteria (mean age 58.9 ± 13.2 years, 63.8% male). Malignancy accounted for 96.7% of cases, with low anterior resection performed in 83.8%. Ileostomy closure was achieved in 364 patients (79.8%) at a median of 6 months (mean 7.4 ± 5.3). The non-reversal rate was 20.2% (92 patients). Main reasons included mortality (35.8%), metastatic disease (23.9%), and anastomotic complications (22.8%). Multivariable analysis identified ASA score 3–4 (OR 2.68, 95% CI 1.58–4.54, p < 0.001) and malignant pathology (OR 5.12, 95% CI 1.23–21.3, p = 0.025) as independent predictors of non-reversal. Age showed statistical but limited clinical significance. Conclusion One in five patients with diverting ileostomies will not undergo reversal. High ASA scores, malignant disease, mortality, metastatic progression, and anastomotic complications are primary barriers. These findings emphasize the need for realistic preoperative counseling regarding permanent stoma risk.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (10)
Hemorrhoidectomy vs. non-Doppler-guided hemorrhoidal artery ligation
SUMMARY OBJECTIVE: Hemorrhoidal disease is one of the most prevalent benign anorectal conditions, and the optimal surgical approach for higher-grade disease remains debated. Conventional excisional hemorrhoidectomy is durable but painful, whereas hemorrhoidal artery ligation with mucopexy is a minimally invasive alternative that aims to reduce morbidity. Although hemorrhoidal artery ligation was originally described as a Doppler-guided procedure, accumulating evidence has questioned whether intraoperative Doppler localization is essential, supporting fixed-position suture ligation as a simpler alternative. We compared conventional hemorrhoidectomy with non-Doppler hemorrhoidal artery ligation combined with mucopexy with respect to perioperative parameters and long-term patient-reported outcomes. METHODS: This single-center retrospective study included patients who underwent conventional hemorrhoidectomy or non-Doppler hemorrhoidal artery ligation combined with mucopexy for hemorrhoidal disease between June 2023 and December 2024. The hemorrhoidal artery ligation combined with mucopexy technique consisted of a full-thickness Z-suture placed approximately 4 cm proximal to the dentate line for arterial ligation, followed by a running mucopexy of four to six mucosal–submucosal bites at 5-mm intervals down to 5 mm above the dentate line, applied to each of the three classical anatomical hemorrhoidal positions (3, 7, and 11 o’clock). Demographic and perioperative data were obtained by chart review. Postoperative outcomes were assessed by a structured telephone interview conducted blinded to the operative technique, using the Hemorrhoidal Disease Symptom Score, the Short Health Scale for Hemorrhoidal Disease, a 0–10 patient satisfaction score, the Visual Analogue Scale for pain, and the Vaizey incontinence score. Recurrence was defined as the patient’s self-reported perception of a symptomatic anal lump and was not confirmed by physical examination. To account for the imbalance in hemorrhoid grade, multivariable logistic regression and a subgroup analysis restricted to grade 3 disease were performed, and effect estimates are reported with 95%CIs. RESULTS: Of 185 patients operated during the study period, 34 were excluded, leaving 151 patients (62 hemorrhoidectomy, 89 hemorrhoidal artery ligation combined with mucopexy). The groups were comparable in sex, age, American Society of Anesthesiologists class, and smoking status (all p>0.05). Hemorrhoid grade distribution differed significantly (p<0.001), with grade 2 disease present only in the hemorrhoidectomy group. Hospital stay was shorter after hemorrhoidal artery ligation combined with mucopexy (0.8±0.4 vs. 1.1±0.6 days; p=0.001). Over a mean follow-up of approximately 29 months, postoperative bleeding, tenesmus, Visual Analogue Scale pain, Vaizey score, patient satisfaction, and Hemorrhoidal Disease Symptom Score did not differ significantly between groups. Recurrence was numerically higher after hemorrhoidal artery ligation combined with mucopexy (25.8 vs. 12.9%; OR 2.35, 95%CI 0.97–5.68) but did not reach statistical significance (p=0.083), and the study was underpowered for this endpoint (post-hoc power 51.8%). The direction of the association persisted after adjustment (aOR 2.21, 95%CI 0.91–5.38) and in the grade 3 subgroup (24.0 vs. 12.8%; OR 2.15, 95%CI 0.73–6.31). Quality of life measured by Short Health Scale for Hemorrhoidal Disease was significantly better (lower) in the hemorrhoidectomy group (6.3±4.3 vs. 8.7±3.9; p<0.001). CONCLUSION: Both techniques achieved comparable symptom control, pain, continence, and satisfaction at long-term follow-up. Non-Doppler hemorrhoidal artery ligation combined with mucopexy offered a shorter hospital stay, while hemorrhoidectomy was associated with better disease-specific quality of life and a numerically lower recurrence rate that persisted after adjustment for hemorrhoid grade but did not reach statistical significance in an underpowered comparison. The results indicate that omission of the Doppler transducer does not compromise the long-term outcomes of hemorrhoidal artery ligation with mucopexy and support an individualized approach to technique selection.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (10)
Open AccessHemorrhoidectomy vs. non-Doppler-guided hemorrhoidal artery ligation
SUMMARY OBJECTIVE: Hemorrhoidal disease is one of the most prevalent benign anorectal conditions, and the optimal surgical approach for higher-grade disease remains debated. Conventional excisional hemorrhoidectomy is durable but painful, whereas hemorrhoidal artery ligation with mucopexy is a minimally invasive alternative that aims to reduce morbidity. Although hemorrhoidal artery ligation was originally described as a Doppler-guided procedure, accumulating evidence has questioned whether intraoperative Doppler localization is essential, supporting fixed-position suture ligation as a simpler alternative. We compared conventional hemorrhoidectomy with non-Doppler hemorrhoidal artery ligation combined with mucopexy with respect to perioperative parameters and long-term patient-reported outcomes. METHODS: This single-center retrospective study included patients who underwent conventional hemorrhoidectomy or non-Doppler hemorrhoidal artery ligation combined with mucopexy for hemorrhoidal disease between June 2023 and December 2024. The hemorrhoidal artery ligation combined with mucopexy technique consisted of a full-thickness Z-suture placed approximately 4 cm proximal to the dentate line for arterial ligation, followed by a running mucopexy of four to six mucosal–submucosal bites at 5-mm intervals down to 5 mm above the dentate line, applied to each of the three classical anatomical hemorrhoidal positions (3, 7, and 11 o’clock). Demographic and perioperative data were obtained by chart review. Postoperative outcomes were assessed by a structured telephone interview conducted blinded to the operative technique, using the Hemorrhoidal Disease Symptom Score, the Short Health Scale for Hemorrhoidal Disease, a 0–10 patient satisfaction score, the Visual Analogue Scale for pain, and the Vaizey incontinence score. Recurrence was defined as the patient’s self-reported perception of a symptomatic anal lump and was not confirmed by physical examination. To account for the imbalance in hemorrhoid grade, multivariable logistic regression and a subgroup analysis restricted to grade 3 disease were performed, and effect estimates are reported with 95%CIs. RESULTS: Of 185 patients operated during the study period, 34 were excluded, leaving 151 patients (62 hemorrhoidectomy, 89 hemorrhoidal artery ligation combined with mucopexy). The groups were comparable in sex, age, American Society of Anesthesiologists class, and smoking status (all p>0.05). Hemorrhoid grade distribution differed significantly (p<0.001), with grade 2 disease present only in the hemorrhoidectomy group. Hospital stay was shorter after hemorrhoidal artery ligation combined with mucopexy (0.8±0.4 vs. 1.1±0.6 days; p=0.001). Over a mean follow-up of approximately 29 months, postoperative bleeding, tenesmus, Visual Analogue Scale pain, Vaizey score, patient satisfaction, and Hemorrhoidal Disease Symptom Score did not differ significantly between groups. Recurrence was numerically higher after hemorrhoidal artery ligation combined with mucopexy (25.8 vs. 12.9%; OR 2.35, 95%CI 0.97–5.68) but did not reach statistical significance (p=0.083), and the study was underpowered for this endpoint (post-hoc power 51.8%). The direction of the association persisted after adjustment (aOR 2.21, 95%CI 0.91–5.38) and in the grade 3 subgroup (24.0 vs. 12.8%; OR 2.15, 95%CI 0.73–6.31). Quality of life measured by Short Health Scale for Hemorrhoidal Disease was significantly better (lower) in the hemorrhoidectomy group (6.3±4.3 vs. 8.7±3.9; p<0.001). CONCLUSION: Both techniques achieved comparable symptom control, pain, continence, and satisfaction at long-term follow-up. Non-Doppler hemorrhoidal artery ligation combined with mucopexy offered a shorter hospital stay, while hemorrhoidectomy was associated with better disease-specific quality of life and a numerically lower recurrence rate that persisted after adjustment for hemorrhoid grade but did not reach statistical significance in an underpowered comparison. The results indicate that omission of the Doppler transducer does not compromise the long-term outcomes of hemorrhoidal artery ligation with mucopexy and support an individualized approach to technique selection.
- Open Access
- 31 December 2025
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 41 (6) , 573-585
Patient-reported outcomes after hemorrhoid surgery: early results from a prospective, nationwide, real-world, cohort study on diverse approaches
Purpose: Real-world evidence comparing surgical techniques for symptomatic hemorrhoidal disease (HD) remains limited, despite the availability of multiple approaches. This study aimed to evaluate short-term, interim outcomes from a prospective, nationwide cohort study that compared the effectiveness of different operative techniques based on patient-reported outcome measures (PROMs) in patients with symptomatic HD.Methods: A prospective, nationwide cohort study was conducted at 20 tertiary care centers across Turkiye between July 2022 and July 2024. Adult patients aged 18 years or older with symptomatic HD (grades I–IV) who underwent surgery during this period were included. The choice of procedure was determined by the operating surgeon, and patients were categorized into excisional, fixative, and ablative groups according to the surgical approach used. The primary outcomes were changes in the Hemorrhoidal Disease Symptom Score, Short Health ScaleHD, visual analog scale for pain, and patient satisfaction, assessed from the preoperative period to postoperative day 7 and postoperative week 6.Results: The study included a total of 315 patients after excluding those who did not fulfil the inclusion criteria. Among them, 239 (78.9%) were male, with a mean age of 43.7±11.7 years. The distribution of patients across surgical groups was 207 (65.7%) in the excisional group, 30 (9.5%) in the fixative group, and 78 (24.8%) in the ablative group. All groups demonstrated significant improvements in PROM scores from preoperative to postoperative assessments. However, no statistically significant differences were observed between groups at any time point for PROM scores or for changes in PROM scores across consecutive evaluations (P≥0.05 for all comparisons). Urinary retention occurred more frequently, and hospital stays were longer in the fixative group (P=0.006 and P<0.001, respectively). The excisional group had a greater need for narcotic use and longer duration of use (P=0.003 and P<0.001, respectively).Conclusion: This real-world cohort study shows that all 3 surgical approaches are effective for HD, providing comparable short-term symptomatic relief and patient satisfaction. These techniques appear equally valid treatment options, and the choice of procedure may best be individualized based on patient-specific characteristics and surgeon preference.Trial registration: ClinicalTrials.gov identifier: NCT05429060
- 31 December 2025
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 41 (6) , 573-585
Open AccessPatient-reported outcomes after hemorrhoid surgery: early results from a prospective, nationwide, real-world, cohort study on diverse approaches
Purpose: Real-world evidence comparing surgical techniques for symptomatic hemorrhoidal disease (HD) remains limited, despite the availability of multiple approaches. This study aimed to evaluate short-term, interim outcomes from a prospective, nationwide cohort study that compared the effectiveness of different operative techniques based on patient-reported outcome measures (PROMs) in patients with symptomatic HD.Methods: A prospective, nationwide cohort study was conducted at 20 tertiary care centers across Turkiye between July 2022 and July 2024. Adult patients aged 18 years or older with symptomatic HD (grades I–IV) who underwent surgery during this period were included. The choice of procedure was determined by the operating surgeon, and patients were categorized into excisional, fixative, and ablative groups according to the surgical approach used. The primary outcomes were changes in the Hemorrhoidal Disease Symptom Score, Short Health ScaleHD, visual analog scale for pain, and patient satisfaction, assessed from the preoperative period to postoperative day 7 and postoperative week 6.Results: The study included a total of 315 patients after excluding those who did not fulfil the inclusion criteria. Among them, 239 (78.9%) were male, with a mean age of 43.7±11.7 years. The distribution of patients across surgical groups was 207 (65.7%) in the excisional group, 30 (9.5%) in the fixative group, and 78 (24.8%) in the ablative group. All groups demonstrated significant improvements in PROM scores from preoperative to postoperative assessments. However, no statistically significant differences were observed between groups at any time point for PROM scores or for changes in PROM scores across consecutive evaluations (P≥0.05 for all comparisons). Urinary retention occurred more frequently, and hospital stays were longer in the fixative group (P=0.006 and P<0.001, respectively). The excisional group had a greater need for narcotic use and longer duration of use (P=0.003 and P<0.001, respectively).Conclusion: This real-world cohort study shows that all 3 surgical approaches are effective for HD, providing comparable short-term symptomatic relief and patient satisfaction. These techniques appear equally valid treatment options, and the choice of procedure may best be individualized based on patient-specific characteristics and surgeon preference.Trial registration: ClinicalTrials.gov identifier: NCT05429060
- Open Access
- 9 August 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25 (1) , 350
The impact of uterine manipulator assistance on intraoperative exposure and outcomes in laparoscopic rectal cancer surgery
Laparoscopic rectal surgery in female patients poses challenges due to limited pelvic space and obstructing reproductive structures. Uterine manipulators, widely used in gynecological surgery, may enhance intraoperative exposure during rectal resections, but evidence in colorectal settings is sparse. This retrospective cohort study included 40 female patients undergoing laparoscopic rectal cancer surgery between October 2024 and January 2025. Patients were divided into two groups based on the use of a uterine manipulator. Preoperative characteristics, intraoperative findings, and postoperative outcomes were compared, including exposure quality, operative time, lymph node harvest, neoadjuvant treatment response, and recovery parameters. Intraoperative exposure was significantly better in the manipulator group (VAS 8.8 ± 0.9 vs. 6.05 ± 1.5; p < 0.001). Other perioperative parameters such as operative time, bleeding, lymph node harvest, and ICU admission showed no statistically significant differences. Among patients who received neoadjuvant therapy, pathological response did not differ between groups. Hospital stay was slightly shorter and pain scores marginally higher in the manipulator group, without statistical significance. Uterine manipulators significantly improve exposure during laparoscopic rectal surgery in women without adversely affecting oncological or perioperative outcomes. They may be considered a useful adjunct in challenging pelvic dissections.
- 9 August 2025
- Published by Springer Nature in BMC Surgery
- Vol. 25 (1) , 350
Open AccessThe impact of uterine manipulator assistance on intraoperative exposure and outcomes in laparoscopic rectal cancer surgery
Laparoscopic rectal surgery in female patients poses challenges due to limited pelvic space and obstructing reproductive structures. Uterine manipulators, widely used in gynecological surgery, may enhance intraoperative exposure during rectal resections, but evidence in colorectal settings is sparse. This retrospective cohort study included 40 female patients undergoing laparoscopic rectal cancer surgery between October 2024 and January 2025. Patients were divided into two groups based on the use of a uterine manipulator. Preoperative characteristics, intraoperative findings, and postoperative outcomes were compared, including exposure quality, operative time, lymph node harvest, neoadjuvant treatment response, and recovery parameters. Intraoperative exposure was significantly better in the manipulator group (VAS 8.8 ± 0.9 vs. 6.05 ± 1.5; p < 0.001). Other perioperative parameters such as operative time, bleeding, lymph node harvest, and ICU admission showed no statistically significant differences. Among patients who received neoadjuvant therapy, pathological response did not differ between groups. Hospital stay was slightly shorter and pain scores marginally higher in the manipulator group, without statistical significance. Uterine manipulators significantly improve exposure during laparoscopic rectal surgery in women without adversely affecting oncological or perioperative outcomes. They may be considered a useful adjunct in challenging pelvic dissections.
- 2 December 2024
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 29 (1) , 1-6
Comparative outcomes of standard laser fistula closure (filac) versus filac combined with advancement flap in the treatment of complex anal fistulas
Aim This study aims to compare the clinical outcomes of patients treated for complex anal fistulas using standard laser fistula closure (FiLaC) versus FiLaC combined with an advancement flap (+FLAP). Methods A retrospective review was conducted on patients treated for complex anal fistulas between January 2022 and December 2023. Treatments included standard FiLaC and FiLaC combined with an advancement flap. Main outcome measures included operation duration, hospital stay, postoperative pain [Visual Analog Scale (VAS) score], complications, and success rate. Results A total of 47 patients were included in the study, with 25 in the standard FiLaC group and 22 in the +FLAP group. The +FLAP group had significantly longer operation times (29.7 ± 4.7 min versus 18.7 ± 4.0 min, p < 0.001) and hospital stays (16.2 ± 5.04 h versus 3.9 ± 2.3 h p < 0.001). Postoperative pain scores were similar between groups. The mean follow-up periods for the FILAC and +FLAP groups were 10.5 ± 3.5 months and 8.4 ± 4.0 months, respectively. The success rate was significantly higher in the +FLAP group (95.5% versus 72%, p = 0.03). Conclusion In this study, we found that, compared with FiLAC alone, combining FiLaC with an advancement flap may significantly improve primary success rates in the treatment of complex anal fistulas, and we believe this approach could be a valuable option for enhancing treatment outcomes in complex cases. The increased operation and hospital stay durations appear to be balanced by the higher success rates.
- 2 December 2024
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 29 (1) , 1-6
Comparative outcomes of standard laser fistula closure (filac) versus filac combined with advancement flap in the treatment of complex anal fistulas
Aim This study aims to compare the clinical outcomes of patients treated for complex anal fistulas using standard laser fistula closure (FiLaC) versus FiLaC combined with an advancement flap (+FLAP). Methods A retrospective review was conducted on patients treated for complex anal fistulas between January 2022 and December 2023. Treatments included standard FiLaC and FiLaC combined with an advancement flap. Main outcome measures included operation duration, hospital stay, postoperative pain [Visual Analog Scale (VAS) score], complications, and success rate. Results A total of 47 patients were included in the study, with 25 in the standard FiLaC group and 22 in the +FLAP group. The +FLAP group had significantly longer operation times (29.7 ± 4.7 min versus 18.7 ± 4.0 min, p < 0.001) and hospital stays (16.2 ± 5.04 h versus 3.9 ± 2.3 h p < 0.001). Postoperative pain scores were similar between groups. The mean follow-up periods for the FILAC and +FLAP groups were 10.5 ± 3.5 months and 8.4 ± 4.0 months, respectively. The success rate was significantly higher in the +FLAP group (95.5% versus 72%, p = 0.03). Conclusion In this study, we found that, compared with FiLAC alone, combining FiLaC with an advancement flap may significantly improve primary success rates in the treatment of complex anal fistulas, and we believe this approach could be a valuable option for enhancing treatment outcomes in complex cases. The increased operation and hospital stay durations appear to be balanced by the higher success rates.
- Open Access
- 9 September 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (3) , 383-389
Comparison of The Effect of Candida Score and Candida Colonization Index on Decrease in Candidemia Incidence in Our Intensive Care Unit
Aim: Since candidemia is an important cause of mortality and morbidity in hospitals, especially in intensive care units (ICU), those hospitalized in the ICU; In patients with risk factors such as invasive device use and undergoing abdominal surgery, early empirical antifungal therapy is recommended to reduce mortality according to the results of candida score (CS) and candida colonization index (CCI). In this study, the data of the patients who were followed up in the ICU, who were started on empirical treatment according to KS and CCI, were evaluated and their effects on the incidence of candidemia were analyzed. Method: Cultures taken from 100 patients hospitalized in the intensive care unit where adult patients were followed between 01.06.2018 and 01.08.2021 were examined. While investigating the colonization index of each patient, swab samples were taken once during the hospitalization from five main sites: mouth, nose, skin, perineum, and catheter. Samples taken with sterile swabs were inoculated on Sabouraud dextrose agar (SDA) plates and the plates were incubated at 35°C for 48 hours. The yeast colonies formed were defined according to their microscopic appearance and biochemical properties. CCI and CS of the patients were evaluated and fluconazole prophylaxis was started in patients with KS ≥3 or CCI ≥0.5. Results: A total of 500 culture samples from 100 non-neutropenic adult patients were analyzed (Mean of 5 cultures/patient). No growth was detected in any of the samples in 32 (32 %) of 100 patients, and growth was detected in at least one of the samples taken from 68 patients (68 %). Reproduction was detected from a total of 118 samples. Of the yeasts, 104 were identified as Candida albicans, 10 as Candida glabrata and 4 as Candida inconspicua. CS≥ 3 and CCI ≥0.5 in 11 (11%) patients, and CS≥3, CCI
- 9 September 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (3) , 383-389
Open AccessComparison of The Effect of Candida Score and Candida Colonization Index on Decrease in Candidemia Incidence in Our Intensive Care Unit
Aim: Since candidemia is an important cause of mortality and morbidity in hospitals, especially in intensive care units (ICU), those hospitalized in the ICU; In patients with risk factors such as invasive device use and undergoing abdominal surgery, early empirical antifungal therapy is recommended to reduce mortality according to the results of candida score (CS) and candida colonization index (CCI). In this study, the data of the patients who were followed up in the ICU, who were started on empirical treatment according to KS and CCI, were evaluated and their effects on the incidence of candidemia were analyzed. Method: Cultures taken from 100 patients hospitalized in the intensive care unit where adult patients were followed between 01.06.2018 and 01.08.2021 were examined. While investigating the colonization index of each patient, swab samples were taken once during the hospitalization from five main sites: mouth, nose, skin, perineum, and catheter. Samples taken with sterile swabs were inoculated on Sabouraud dextrose agar (SDA) plates and the plates were incubated at 35°C for 48 hours. The yeast colonies formed were defined according to their microscopic appearance and biochemical properties. CCI and CS of the patients were evaluated and fluconazole prophylaxis was started in patients with KS ≥3 or CCI ≥0.5. Results: A total of 500 culture samples from 100 non-neutropenic adult patients were analyzed (Mean of 5 cultures/patient). No growth was detected in any of the samples in 32 (32 %) of 100 patients, and growth was detected in at least one of the samples taken from 68 patients (68 %). Reproduction was detected from a total of 118 samples. Of the yeasts, 104 were identified as Candida albicans, 10 as Candida glabrata and 4 as Candida inconspicua. CS≥ 3 and CCI ≥0.5 in 11 (11%) patients, and CS≥3, CCI
- 8 August 2023
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (1) , 89-95
Treatment results of our patients with acute viral hepatitis C
- 8 August 2023
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (1) , 89-95
Treatment results of our patients with acute viral hepatitis C